Abstract library

311 results for "lymphatic metastasis".
#2007 The Exact Prognostic Significance of Lymphatic Metastasis of Jejunoileal Neuroendocrine Tumors
Introduction: How to evaluate the prognostic significance of lymphatic metastasis in patients with jejunoileal neuroendocrine tumors (jNETs) is still not conclusive.
Conference: 15th Annual ENETS conference (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Professor Jie Chen
Authors: Zhang Y, Chen L, Song Y, Chen M, ...
#1539 Slit-Robo Signaling Links to Ras Activity to Suppress Metastasis and Is Associated with Time-to-Progression in Pancreatic Neuroendocrine Tumors
Introduction: mRNA signatures of distinct metastatic phenotypes of pancreatic NETs (pNETs) exhibit differences in several components of the Slit-Robo axon guidance system.
Conference: 13th Annual ENETS conference (2016)
Category: Basic Science - mTOR and other pathways, signalling, receptors
Presenting Author: PD Dr. med. Christian Fischer
#1071 Pathological Factors Predicting Recurrence of the Non-Functioning Pancreatic NET after Resection
Introduction: The usefulness of the WHO 2010 classification for surgeons has not been elucidated, since the criteria is defined by cell growth with Ki67 and may not represent invasiveness of the tumor as well as the recurrence type (liver metastasis or lymph node metastasis)
Conference: 12th Annual ENETS Conference (2015)
Category: Surgical treatment
Presenting Author: M.D., Ph.D. Toshihiko Masui
Authors: Masui T, Sato A, Takaori K, Uemoto S, ...
#25 Predictors of response to radio-embolization (TheraSphere ®) treatment of neuro-endocrine liver metastasis
Introduction: Neuroendocrine tumors (NET) frequently metastasize to the liver. Most patients have diffuse, and therefore incurable, disease. NET liver metastasis has been shown to respond to yttrium-90 microspheres therapy. This study aims to define factors that predict response to radio-embolization in patients with NET liver metastases.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Mazen Hassanain
#116 Transarterial chemoembolization (TACE) of liver metastasis from pancreatic well-differentiated endocrine carcinoma
Introduction: The behavior of liver metastasis from endocrine pancreatic carcinoma is eterogeneous, and several treatments have been proposed, but no single option is ideal.
Conference: 7th Annual ENETS Conference (2010)
Category: Basic
Presenting Author: MD Vanessa Capitanio
Authors: Capitanio V, Papa M, Zerbi A, Vitali G, ...
#632 Strategy of Combining Liver-directed Local Treatment with Systemic Treatment in Patients with Liver Metastasis of Neuroendocrine Tumor
Introduction: Little is known about the clinical outcomes of liver-directed local treatment (tx) in combination with systemic tx in patients with liver metastasis of neuroendocrine tumor (NET).
Conference: 10th Annual ENETS Conference (2013)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Professor Do-Youn Oh
Authors: Kim S, Kim J, Han S, Oh D Y, ...
#1428 Factors Affecting Recurrences of the Non-functioning Pancreatic NET After Resection
Introduction: In 2010, WHO classification has been modified. However, the usefulness of the criteria for surgeons has not been elucidated, because the criteria is defined by cell growth represented by Ki67 for overall survival and may not represent invasiveness of the tumor.
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: M.D., Ph.D. Toshihiko Masui
Authors: Masui T, Sato A, Nakano K, Nakamoto Y, ...
Keywords: WHO2010, invasiveness
#1861 Surgical Strategies and Selection Criteria for Patients with Liver Metastasis from Neuroendocrine Tumors: Personal Experience.
Introduction: The role of surgical treatment of liver metastasis from neuroendocrine neoplasm(NET) is still a debated issue,and the management of these patients is entrusted to the practical experience of single centers.The main problem is that there are not available randomized trials comparing surgical resection to unthreated patients or other liver directed therapy.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Dr Bruno Pauletti
#1938 Eleven Years Survival after Combined Treatment of Surgery, Ultrasound-Guided Radiofrequency Ablation of Liver Metastasis, CT Embolization Plus Somatostatin LAR in a Case with Atypical Carcinoid of the Lung
Introduction: The combination of different therapeutic methods has an important place in the treatment of patients with NET and liver metastasis, ineligible for radical surgery.
Conference: 14th Annual ENETS conference (2017)
Category: PRRT-Ablative therapies- Endoscopic treatment, surgical treatment
Presenting Author: Prof. Borislav Vladimirov
#2040 Hepatic Tumor Burden Can Be Reduced Rapidly and Effectively by Trans-Arterial Embolization Combined with Systemic Therapy in Patients with Neuroendocrine Tumor Liver Metastasis (NETLM)
Introduction: The main tumor burden of patients with neuroendocrine tumor liver metastasis is comprised by hepatic lesions.
Conference: 15th Annual ENETS conference (2018)
Category: Imaging and Interventions (radiology, endoscopy)
Presenting Author: Yiming Liu
Authors: Liu Y, Wang Y, Lian F, Shen L, ...